UK Vaunts 'New Era' In Drug Approvals
Several New Routes To Market Are Now Available To Applicants
The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.
